Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 29, 2017

DrugPatentWatch Database Preview

Oxaprozin - Generic Drug Details

« Back to Dashboard

What are the generic sources for oxaprozin and what is the scope of oxaprozin patent protection?

Oxaprozin
is the generic ingredient in three branded drugs marketed by Gd Searle, Sandoz, Actavis Elizabeth, Sun Pharm Inds Inc, Ivax Sub Teva Pharms, Mylan Pharms Inc, Watson Labs, Teva, Mylan, Dr Reddys Labs Ltd, and Apotex Inc, and is included in fourteen NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are thirteen drug master file entries for oxaprozin. Twenty-two suppliers are listed for this compound.

Summary for Generic Name: oxaprozin

Tradenames:3
Patents:1
Applicants:11
NDAs:14
Drug Master File Entries: see list13
Suppliers / Packagers: see list22
Bulk Api Vendors: see list65
Clinical Trials: see list3
Patent Applications: see list6,671
Therapeutic Class:Anti-inflammatory Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:oxaprozin at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Elizabeth
OXAPROZIN
oxaprozin
TABLET;ORAL075843-001Oct 3, 2001DISCNNoNo► Subscribe► Subscribe
Sandoz
OXAPROZIN
oxaprozin
TABLET;ORAL075845-001Jan 31, 2001ABRXNoNo► Subscribe► Subscribe
Sandoz
OXAPROZIN
oxaprozin
TABLET;ORAL075842-001Apr 12, 2001DISCNNoNo► Subscribe► Subscribe
Gd Searle
DAYPRO ALTA
oxaprozin potassium
TABLET;ORAL020776-001Oct 17, 2002DISCNNoNo► Subscribe► Subscribe
Watson Labs
OXAPROZIN
oxaprozin
TABLET;ORAL075848-001Feb 9, 2001DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Predict branded drug patent expiration
  • Obtain formulation and manufacturing information
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot